Fig. 1
From: Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy
Comparison of conventional vaccination and ISV. (a) Conventional vaccination. (b) ISV. Copyright 2018, Wiley Interdiscip Rev Nanomed Nanobiotechnol
Fig. 1 | Journal of Hematology & Oncology